BriefMD

Specialties / Global Health

New Global Health research.

The strongest recent Global Health papers on PubMed, ranked by study design, topic and journal, with the same summaries subscribers get.

  1. randomized trial, 1,404 patients

    Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China

    Shi X, Han S, Wu C, et al. Hum Vaccin Immunother. Dec 2026.

    Findings
    A total of 1,404 adults aged ≥ 18 year, with equal numbers of adults aged 18-59 year and ≥60 year, were randomized 1:1:1 to receive WIBP-CorV + PPV23 on Day 0 followed by WIBP-CorV + IIV4 on Day 28, WIBP-CorV alone on Days 0 and 28, or PPV23 on Day 0 followed by IIV4 on Day 28.
    Bottom line
    The study enrolled 1,404 participants aged ≥ 18 year and allocated them in a 1:1:1 ratio across three vaccination schedules using Day 0 and Day 28 dosing intervals.

    PubMed, PMID 42904667

  2. randomized trial, 200 patients

    Wireless Home Blood Pressure Monitoring With Health Coaching for Hypertension Management at a Federally Qualified Health Center: Pilot Randomized Controlled Feasibility and Acceptability Study

    Magalit N, Moran R, Narezkina A, et al. JMIR Form Res. Oct 2026.

    Findings
    Of 316 recruited participants, 290 (92%) were eligible and 200 (63%) were analyzed (wireless: n=73, 23%; standard: n=127, 40%). Among wireless participants, 86% (63/73) transmitted multiple readings (mean 160.6, SD 129.1) over 6 months, achieving 76.2% (160/210) of expected readings among transmitters and 66% across all 73. Only 5% (7/127) of standard‑arm participants returned paper logs.
    Bottom line
    66% overall transmission; 5% returned logs

    PubMed, PMID 42912953

  3. meta-analysis, 52 studies

    Short-term outcomes after major lower limb amputation: meta-analysis

    Moody N, Nielsen R, Lyons M, et al. BJS Open. Sep 2026.

    Findings
    A systematic review of 52 studies covering 1 067 616 patients found a point estimate of 10.0% with a 95% confidence interval of 8.2% to 12.1%.
    Bottom line
    The pooled estimate is 10.0% (8.2%–12.1%) across 52 studies and 1 067 616 patients.

    PubMed, PMID 42925092

  4. meta-analysis, 246 studies

    Global gram-negative diabetic foot infection prevalence and its associations with climate: a systematic review and meta-analysis

    Schechter MC, Rabin B, Martinson E, et al. BMC Infect Dis. Jul 2026.

    Findings
    The review identified 246 studies with 36,788 participants and found a 19% prevalence (95% CI 17‑22%).
    Bottom line
    Gram‑negative infection occurs in about one‑fifth of cases, based on 246 studies and 36,788 participants.

    PubMed, PMID 42919169

  5. meta-analysis, 9,429 patients

    Fasinumab for osteoarthritis: a systematic review and meta-analysis of efficacy and safety

    Khan MS, Moeen W, Banatwala UESS, et al. BMC Musculoskelet Disord. Jul 2026.

    Findings
    A systematic review and meta‑analysis of 6 randomized controlled trials involving 9,429 participants evaluated fasinumab for osteoarthritis. The analysis indicated a potential increase in adverse events, including joint‑replacement surgery and adjudicated arthropathy.
    Bottom line
    Evidence from 6 trials with 9,429 participants suggests fasinumab may raise safety concerns.

    PubMed, PMID 42902285

Summaries are written by AI from PubMed abstracts, for keeping up with the literature. Check the source before it changes care. Editorial policy · Medical disclaimer

Get Global Health research every morning.

Free. Choose your Global Health topics after you subscribe.